Abiopharma

🔍 Sanche Jacques Wolf (Director)

Company: Amrize Ltd (AMRZ)

Report Date: 2026-08-26

Detailed Transactions and Holdings:

• Acquired 4,150 shares of Ordinary Shares at $45.02 per share (Direct)
  Date: 2026-08-26 | Code: P | equity_swap_involved: 0 | shares_owned_after: 9,766.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Ordinary Shares (Direct)
  Date: 2026-08-26 | Code: H | nature_of_ownership: By child | shares_owned_after: 40.00

Footnotes:

• F1: The shares were purchased in multiple transactions at prices ranging from CHF 36.17 to CHF 36.19, inclusive. This amount represents the CHF 36.18 weighted average price of such transactions, and such price was converted into US Dollars using the transaction date exchange rate of (USD 1.00 = CHF 0.8036). The reporting person undertakes to provide full information regarding the number of shares purchased at each separate price upon request of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.